BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 5:40:00 PM | Browse: 1126 | Download: 1194
 |
Received |
|
2013-10-29 11:03 |
 |
Peer-Review Started |
|
2013-10-29 20:56 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-11-19 15:59 |
 |
Revised |
|
2013-11-29 17:26 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-12-19 13:01 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-12-19 13:27 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-12-30 19:23 |
 |
Typeset the Manuscript |
|
2014-01-09 18:01 |
 |
Publish the Manuscript Online |
|
2014-01-16 15:24 |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Case Report |
| Article Title |
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Gian Marco Rosa, Antonello Parodi, Ulrico Dorighi, Federico Carbone, François Mach, Alessandra Quercioli, Fabrizio Montecucco, Nicolas Vuilleumier, Manrico Balbi and Claudio Brunelli |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Swiss National Science Foundation |
310030_118245 |
| Swiss National Science Foundation |
32003B_134963/1 |
|
| Corresponding Author |
Fabrizio Montecucco, MD, PhD, Division of Cardiology, Department of Internal Medicine, Foundation for Medical Researches, University of Geneva, 6 viale Benedetto XV, 1211 Geneva, Switzerland. fabrizio.montecucco@unige.ch |
| Key Words |
Mitral valve; Thrombus; Prosthetic valve; Atrium; Hepatotoxicity |
| Core Tip |
Thromboembolism represents an important complication following heart valve replacement. This case report shows that although vitamin K antagonist (VKA) treatment represents the elective therapy in patients with left atrial thrombosis without mitral valve dysfunction, it may not be sufficient to avoid thrombogenesis. We also recommend that the discontinuation of VKA during the first three months after mitral valve surgery has to be carefully considered, especially in high thromboembolic risk patients. |
| Publish Date |
2014-01-16 15:24 |
| Citation |
Rosa GM, Parodi A, Dorighi U, Carbone F, Mach F, Quercioli A, Montecucco F, Vuilleumier N, Balbi M, Brunelli C. Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case. World J Clin Cases 2014; 2(1): 20-23 |
| URL |
http://www.wjgnet.com/2307-8960/full/v2/i1/20.htm |
| DOI |
http://dx.doi.org/10.12998/wjcc.v2.i1.20 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345